HOME | CONTACT | BLOG | SITE MAP   

Management Team

Robert J. Harman, D.V.M., M.P.V.M. - Founder, Chief Executive Officer
Dr. Harman has more than 22 years of experience as a chief executive officer and biotechnology entrepreneur in four novel businesses, all financial successes. Dr. Harman is a veterinarian and statistician, and has overseen the completion of more than 1,000 contract research projects in his career for the development of veterinary and human biotechnology products. He has led the following companies: HTI Bio-Services, a contract research company; HTI Bio-Products, a biological reagent and antibody production company; and Animal Health Ventures, a veterinary product licensing company.
Carolyn Wrightson, Ph.D. - Chief Operating Officer
Dr. Wrightson has more than 20 years of experience in biochemistry, molecular biology, and molecular pathology. Her expertise lies in scale-up of research technologies into high-throughput services, implementation of regulatory compliance, project management, and product development. Dr. Wrightson has experience in research and development, information systems and process development, lean systems analysis and implementation, intellectual property, and contract management.
Jeffrey Schaffer, D.V.M. - Vice President of Sales, Marketing and Professional Services
Dr. Schaffer obtained his Doctor of Veterinary Medicine at the University of Perugia. He was the Director of Animal Health at PALL Life Sciences, overseeing product distribution with over 100 sales representatives. Dr. Schaffer has over 15 years experience in the Regenerative Medicine field. He was the lead in the development, marketing and launch of the PALL V-PET™ platelet therapy system. Dr. Schaffer has practiced veterinary medicine at Nassau-Suffolk Vet Hospital, several emergency veterinary hospitals and animal shelters and also worked as a professor in medical and biological subjects at numerous colleges and universities in New York. He is the author of a range of published studies and has established relationships with opinion leaders in medical, veterinary research and clinical practice.
Mark Hughes, D.V.M. - Senior Manager, Veterinary Clinical Research and Safety
Dr. Hughes, former Product Development Manager in R&D at Virbac Corporation, brings eight years of experience managing drug development projects through the process of pharmaceutical development, preclinical and clinical trials, and submissions to regulatory authorities for marketing approval in the US and Canada. Dr. Hughes received BS, MS, and DVM degrees from the University of California, Davis, and is licensed to practice in California. He also has provided commercial embryo transfer services for beef and dairy cattle, developed in-vitro diagnostics for diseases in animals and people, and managed a laboratory animal research facility. span>
Kevin Hicok, M.S. - Director, Research and Development
Mr. Hicok has over 20 years of research experience in the field of adult stem and regenerative cell therapeutics, including bone marrow derived and fat derived culture expanded mesenchymal stem cells (MSCs) as well as primary adipose derived regenerative cells. His experience includes R&D positions with Osiris Therapeutics, Artecel Sciences, Cytori Therapeutics, and the Mayo Clinic. With his expereince in managing basic and applied research groups, as well as expertise in applying GLP, GTP and cGMP quality standards to research practice, he supports the development team to gain FDA approval for all allogeneic stem cell therapies. span>

Board of Directors

Michael Dale, B.S. - Founder
Mr. Dale has extensive business and managerial experience with multiple start-up biotech companies, and was co-founder of HTI Bio-Products, a biological reagent and antibody company. His expertise covers start-up and scale-up of operations; sales and marketing; data systems; and production. Mr. Dale and Dr. Harman have been partners for numerous years in biotechnology and veterinary service businesses.
Erwin F. Workman, Jr., PhD
Erwin F. Workman, Jr., PhD, has over 26 years of successful diagnostic and scientific development experience with IDEXX Laboratories, Inc. (IDXX) and Abbott Laboratories, Inc. (ABT). Dr. Workman was a key participant in the creation of the world’s largest veterinary diagnostic company, IDEXX Laboratories, Inc. Dr. Workman helped lead IDEXX Laboratories, Inc. through startup, new product development, initial profitability, global expansion and a successful IPO. Prior to joining IDEXX Laboratories, Inc. Dr. Workman oversaw and directed the Research and Development of the Hepatitis and AIDS business unit of Abbott Laboratories, Inc. Dr. Workman’s position on the Board of Directors for VetStem will serve the purpose of leading strategic planning and execution for current and future services and products.
Linda F. Powers, JD
Linda F. Powers, JD sits on the board of directors for seven biotech companies, and is Chair of the Maryland Stem Cell Research Commission which administers the state’s stem cell funding program. She is on the Advisory Board of US Department of Commerce NIST Advanced Technology Program, a Board Member of the Trudeau Institute, Moffitt Technology Corporation, and NorthWest Biotherapeutics. Ms. Powers is Co-Founder of Toucan Management, LLC. and is experienced in venture capital investing and joint ventures.
Michael J. McCloskey, DVM
Michael J. McCloskey, DVM, obtained his Doctorate of Veterinary Medicine with post-doctoral study in Dairy Production Medicine. He received the Alumni Achievement Award from the University of California at Davis, School of Veterinary Medicine, and went on to Co-Found and serves as CEO of Select Milk Producers. Dr. McCloskey founded and serves as the acting Chair of Southwest Cheese Company, and is Chairman of the Board for Fair Oaks Farms. He is a Partner and General Manager of Fair Oaks Dairy Farms, and Member of Markle Initiative for America’s Economic Future in a Networked World. Dr. McCloskey brings multi-national agribusiness and patent experience to VetStem’s Board.


Locate a Vet
Visit our locate a vet page
for a qualified VetStem veterinarian in your area.>LOCATE A VET

Pet & Horse Owners
Arthritis in Dogs & Cats and Tendons & Ligaments in Horses can be treated with regenerative stem cells from your animal's own fat. >LEARN MORE

Veterinarians
Is stem cell therapy right for your patients? See why over 8,000 animals have been treated with VetStem Regenerative Medicine. >LEARN MORE
Management
Investors
Contact Us
Careers
 
 


  COMPANY
Management
Investors
Contact Us
Careers
Privacy Policy
SCIENCE
FAQs
Literature Refs
Safety
PET & HORSE OWNERS
Dogs & Cats
Horses
Locate a Vet
FAQs
VETERINARIANS
Vet Login /
Credentialing

Dogs & Cats
Horses
FAQs
MEDIA ROOM
Press Releases
Success Stories
News
Videos
Blog
LOCATE A VET

CONTACT US
 

COPYRIGHT 2011 VETSTEM BIOPHARMA. ALL RIGHTS RESERVED.
12860 Danielson Court, Suite B, Poway, CA 92064 Phone: 858-748-2004 or 888-387-8361